1 / 6

Biologics Safety Testing Market

The size of global biologics safety testing market in terms of revenue was estimated to be worth $4.2 billion in 2024 and is poised to reach $7.2 billion by 2029, growing at a CAGR of 11.1% from 2024 to 2029.

Rachel38
Download Presentation

Biologics Safety Testing Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Biologics Safety Testing Market Global Forecast to 2029 Biologics Safety Testing Market is expected to reach USD 7.2 billion by 2029 Growing at a CAGR of 11.1% (2024 – 2029)

  2. Single Use Bioprocessing Market MARKET OPPORTUNITY OVER NEXT 5 YEARS KEY MARKET PLAYERS by TEST Type CAGR of 2024 – 2029 • Thermo Fisher Scientific Inc. (US) • Merck KGaA (Germany) • Lonza (Switzerland) • FUJIFILM Corporation (Japan) • Sartorius AG (Germany) • F. Hoffmann-La Roche Ltd (Switzerland) CAGR • Mycoplasma Tests • Sterility Tests • Endotoxin Tests • Virus Safety Tests By End User BY REGION North America Europe Asia Pacific Rest of the World • Pharmaceutical & Biotechnology Companies • CROs and CDMOs • Academic and Research Institutes

  3. The size of global biologics safety testing market in terms of revenue was estimated to be worth $4.2 billion in 2024 and is poised to reach $7.2 billion by 2029, growing at a CAGR of 11.1% from 2024 to 2029. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. Growth of the market can be attributed to factors such as the rising need for novel biotherapeutics and increasing focus on advancement of biopharmaceutical industry. However, ethical concern about animal testing may hamper the growth of the market. Download PDF Brochure:

  4. The Biologics Safety Testing Market is dominated by players such as • Thermo Fisher Scientific Inc. (US) • Merck KGaA (Germany) • Lonza (Switzerland) • FUJIFILM Corporation (Japan) • Sartorius AG (Germany) • F. Hoffmann-La Roche Ltd (Switzerland) • Charles River Laboratories (US) • BIOMÉRIEUX (France) • MaravaiLifeSciences (US) • WuXiAppTec (China)

  5. North America dominated the biologics safety testing industry in 2023. The global biologics safety testing market is segmented into six major regions—North America, Europe, the Asia Pacific, Latin America, Middle East, and Africa. North America accounted for the largest share of market in 2023, followed by Europe and the Asia Pacific. Factors such as significant expenditure on R&D activities, presence of a well-established healthcare market, growing need of advanced therapies are responsible for the largest share of North America region in market. Request Sample Pages

  6. Contact: Mr. Rohan Salgarkar MarketsandMarkets Inc. 1615 South Congress Ave. Suite 103, Delray Beach, FL 33445 USA : 1-888-600-6441 UK +44-800-368-9399 Email: sales@marketsandmarkets.com Visit Our Website: https://www.marketsandmarkets.com/

More Related